Clinical Trial Update: IL-6: A Marker for AML Chemo Sensitivity

View source ↗

Summary

A clinical study is evaluating whether interleukin-6 levels can predict chemotherapy response in adults with acute myeloid leukemia; the trial is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: AML, Adult | Status: RECRUITING